Supporting a Future Made in Australia: PolyNovo a Core Partner of SMART CRC

Melbourne, Australia – 11 May 2026

PolyNovo Limited (ASX: PNV), a leading medical technology company transforming the management of complex wounds, is proud to announce that it has become a Core Partner of the Solutions for Manufacturing Advanced Regenerative Therapies (SMART) Cooperative Research Centre (CRC)

This partnership will advance PolyNovo's regenerative medicine capabilities, supports the continued scale-up of manufacturing footprint and aligns the Company with Australia’s Future Made in Australia advanced medical manufacturing agenda.

The SMART CRC is Australia’s national centre for advancing regenerative therapy research, development, and manufacturing, bringing together Australian and multinational biotechnology and pharmaceutical companies with Australia’s leading universities, medical research institutes, and health services. https://smartcrc.com.au/

The CRC co-funded project will explore the use of PolyNovo’s proprietary synthetic scaffold technology (NovoSorb MTX) as part of a lab grown autologous cell‑infused composite skin substitute, with the aim of evaluating its potential as an alternative to autologous split‑skin grafting. Currently autologous split-skin grafting is the standard of care for large surface area wound repair but can be limited by donor site morbidity, graft availability, and extended healing times. The project aims to create a platform that will enable future investigation and application to other cell-infused composite tissue products.

CEO comment:
PolyNovo Chief Executive Officer Bruce Peatey said:

“PolyNovo has a long history of engaging with the brightest scientific minds; from the origins of NovoSorb® to the present, innovative science has been part of our DNA.

With the recent appointment of Dr. Marthe D’Ombrain as Chief Scientific Officer, I am excited to continue to strengthen our engagement with industry and academia to drive the NovoSorb® platform forward.”

Media contact: [email protected]